Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing Thursday on how the ...
In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
The FDA already authorizes the use of experimental drugs under what’s called “compassionate use,” for people with no other ...
Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...
Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results